MacroGenics | MGNX - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Genmab DKK 6M 2M 2025-09
Geron USD 11.26M 146K 2025-12
Gilead Sciences USD 715M 93M 2025-12
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 4.15B 102M 2025-09
Pfizer USD 5.02B 142M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Xencor USD 10.83M 1.75M 2025-12